During the past decade, Saitama Cancer Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saitama Cancer Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Haruhiko Fukuda" with 5 trials sponsored, "Japan Clinical Oncology Group" with 4 trials sponsored, "Sumitomo Pharma Oncology, Inc." with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Cancer Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 9 trials as a collaborator, "Japan Breast Cancer Research Group (JBCRG)" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Yakult Honsha Co., LTD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Saitama Cancer Center" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Colorectal Cancer" (2 trials), "Gastric Cancer" (2 trials) and "Gastric Neoplasm" (2 trials). Many other conditions were trialed in "Saitama Cancer Center" in a lesser frequency.

Most popular intervention types in "Saitama Cancer Center" are "Drug" (18 trials), "Procedure" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PD-0332991" (2 trials), "Paclitaxel" (2 trials), "A: Radiotherapy alone" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saitama Cancer Center" are 15 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Saitama Cancer Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Saitama Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saitama Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Saitama Cancer Center has several departments that took part in Clinical trials: "Hyogo Brain and Heart Center" - 8 trials, "Kondo Clinic for Rheumatism and Orthopaedics" - 5 trials, "Urology department Kuroda Clinic" - 2 trials